μ Opioid receptor: Role for the amino terminus as a determinant of ligand binding affinity

Molecular Brain Research

Volumn 76, Issue 1, 2000, Pages 64-72

  Chaturvedi, Kirti ^a   Shahrestanifar, Mandana ^a   Howells, Richard D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Endomorphin; Fentanyl; Methadone; Morphine; Opioid receptor

Indexed keywords

BREMAZOCINE; CYCLAZOCINE; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FENTANYL; METHADONE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE PEPTIDE;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EMBRYO; HUMAN; HUMAN CELL; KIDNEY CELL; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ALKALOIDS; AMINO ACID SEQUENCE; AMINO ACIDS; CELL LINE; HUMANS; HYDROLYSIS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYSACCHARIDES; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, MU; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0034629233     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00332-0     Document Type: Article

References (55)

1. Befort K., Tabbara L., Bausch S., Chavkin C., Evans C., Kieffer B. The conserved aspartate residue in the third putative transmembrane domain of the δ-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. Mol. Pharmacol. 49:1996;216-223.
2. Befort K., Tabbara L., Kling D., Maigret B., Kieffer B. Role of aromatic transmembrane residues of the δ-opioid receptor in ligand recognition. J. Biol. Chem. 271:1996;10161-10168.
3. Blanpain C., Lee B., Vakili J., Doranz B.J., Govaerts C., Migeotte I., Sharron M., Dupriez V., Vassart G., Doms R.W., Parmentier M. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity. J. Biol. Chem. 274:1999;18902-18908.
4. Bot G., Blake A.D., Li S., Reisine T. Mutagenesis of a single amino acid in the rat μ-opioid receptor discriminates ligand binding. J. Neurochem. 70:1998;358-365.
5. o mediates the coupling of the μ opioid receptor to adenylyl cyclase in cloned neural cells and brains. Proc. Natl. Acad. Sci. U. S. A. 90:1993;4062-4066.
6. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12.
7. Claude P.A., Wotta D.R., Zhang X.H., Prather P.L., McGinn T.M., Erickson L.J., Loh H.H., Law P.Y. Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proc. Natl. Acad. Sci. U. S. A. 93:1996;5715-5719.
8. Dong M., Wang Y., Hadac E.M., Pinon D.L., Holicky E., Miller L.J. Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor. J. Biol. Chem. 274:1999;19161-19167.
9. Evans C.J., Keith D.E. Jr., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
10. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H. Primary structures and expression from a cDNA of rat opioid receptor delta- and mu-subtypes. FEBS Lett. 327:1993;311-314.
11. Fukuda K., Terasako K., Kato S., Mori K. Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ- and μ-opioid receptors. FEBS Lett. 373:1995;177-181.
12. Gioannini T., Foucaud B., Hiller J.M., Hatten M.E., Simon E.J. Lectin binding of solubilized opiate receptors: evidence for their glycoprotein nature. Biochem. Biophys. Res. Commun. 105:1982;1128-1134.
13. Goldstein A., Naidu A. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36:1989;265-272.
14. Hartmann E., Rapoport T.A., Lodish H.F. Predicting the orientation of eukaryotic membrane-spanning proteins. Proc. Natl. Acad. Sci. U. S. A. 86:1989;5786-5790.
15. Hebert C.A., Chuntharapai A., Smith M., Colby T., Kim J., Horuk R. Partial functional mapping of the human interleukin-8 type A receptor. J. Biol. Chem. 268:1993;18549-18553.
16. Hjorth S.A., Thirstrup K., Grandy D.K., Schwartz T.W. Analysis of selective binding epitopes for the κ-opioid receptor antagonist nor-binaltorphimine. Mol. Pharmacol. 47:1995;1089-1094.
17. Howells R.D., Gioannini T., Hiller J.M., Simon E.J. Solubilization and characterization of active opiate binding sites from mammalian brain. J. Pharmacol. Exp. Ther. 222:1982;629-634.
18. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U. S. A. 89:1992;12048-12052.
19. Kong H., Raynor K., Yano H., Takeda J., Bell G.I., Reisine T. Agonists and antagonists bind to different domains of the cloned κ opioid receptor. Proc. Natl. Acad. Sci. U. S. A. 91:1994;8042-8046.
20. Kong H., Raynor K., Yasuda K., Moe S.T., Portoghese P.S., Bell G.I., Reisine T. A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268:1993;23055-23058.
21. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:1985;631-664.
22. Laugwitz K.-I., Offermanns S., Spicher K., Schultz G. Mu and delta opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron. 10:1993;233-242.
23. Law P.-Y., Loh H.H. Regulation of opioid receptor activities. J. Pharmacol. Exp. Ther. 289:1999;607-624.
24. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., Wei L.N. μ Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Mol. Brain Res. 54:1998;321-326.
25. Mansour A., Taylor L.P., Fine J.L., Thompson R.C., Hoversten M.T., Mosberg H.I., Watson S.J., Akil H. Key residues defining the μ-opioid receptor binding pocket: a site-directed mutagenesis study. J. Neurochem. 68:1997;344-353.
26. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
27. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383:1996;819-823.
28. Meng F., Hoversten M.T., Thompson R.C., Taylor L., Watson S.J., Akil H. A chimeric study of the molecular basis of affinity and selectivity of the κ and the δ opioid receptors. J. Biol. Chem. 270:1995;12730-12736.
29. Meng F., Ueda Y., Hoversten M.T., Thompson R.C., Taylor L., Watson S.J., Akil H. Mapping the receptor domains critical for the binding selectivity of δ-opioid receptor ligands. Eur. J. Pharmacol. 311:1996;285-292.
30. Meng F., Xie G.-X., Thompson R.C., Mansour A., Goldstein A., Watson S.J., Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl. Acad. Sci. U. S. A. 90:1993;9954-9958.
31. 5]enkephalin from binding to the δ-opioid receptor. Mol. Pharmacol. 50:1996;1413-1422.
32. Moyle W.R., Campbell R.K., Rao S.N., Ayad N.G., Bernard M.P., Han Y., Wang Y. Model of human chorionic gonadotropin and lutropin receptor interaction that explains signal transduction of the glycoprotein hormones. J. Biol. Chem. 270:1995;20020-20031.
33. Pepin M.-C., Yue S.Y., Roberts E., Wahlestedt C., Walker P. Novel "restoration of function" mutagenesis strategy to identify amino acids of the δ-opioid receptor involved in ligand binding. J. Biol. Chem. 272:1997;9260-9267.
34. Perez H.D., Vilander L., Andrews W.H., Holmes R. Human formyl peptide receptor ligand binding domain(s). J. Biol. Chem. 269:1994;22485-22487.
35. Piros E.T., Hales T.G., Evans C.J. Functional analysis of cloned opioid receptors in transfected cell lines. Neurochem. Res. 21:1996;1277-1285.
36. Prather P.L., McGinn T.M., Erickson L.J., Evans C.J., Loh H.H., Law P.Y. Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J. Biol. Chem. 269:1994;21293-21302.
37. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:1994;330-334.
38. Shahrestanifar M., Howells R.D. Sensitivity of opioid receptor binding to N-substituted maleimides and methanethiosulfonate derivatives. Neurochem. Res. 21:1996;1295-1299.
39. Shahrestanifar M., Wang W.W., Howells R.D. Studies on inhibition of μ and δ opioid receptor binding by dithiothreitol and N-ethylmaleimide. J. Biol. Chem. 271:1996;5505-5512.
40. Singh V.K., Bajpai K., Biswas S., Haq W., Khan M.Y., Mathur K.B. Molecular biology of opioid receptors. Neuroimmunomodulation. 4:1997;285-297.
41. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U. S. A. 94:1997;1544-1549.
42. Strader C.D., Fong T.M., Tota M.R., Underwood D., Dixon R.A.F. Structure and function of G-protein-coupled receptors. Annu. Rev. Biochem. 63:1994;101-132.
43. Surratt C.K., Johnson P.S., Moriwaki A., Seidleck B.K., Blaschak C.J., Wang J.B., Uhl G.R. μ-Opioid receptor: charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269:1994;20548-20553.
44. Thirstrup K., Elling C.E., Hjorth S.A., Schwartz T.W. Construction of a high affinity switch in the κ-opioid receptor. J. Biol. Chem. 271:1996;7875-7878.
45. Thompson R.C., Mansour A., Akil H., Watson S.J. Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron. 11:1993;903-913.
46. Valiquette M., Vu H.K., Yue S.Y., Wahlestedt C., Walker P. Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands. J. Biol. Chem. 271:1996;18789-18796.
47. Wadsworth H.L., Russo D., Nagayama Y., Chazenbalk G.D., Rapoport B. Studies on the role of amino acids 38-45 in the expression of a functional thyrotropin receptor. Mol. Endocrinol. 6:1992;394-398.
48. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R. μ Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10230-10234.
49. Wang J.B., Johnson P.S., Wu J.M., Wang W.F., Uhl G.R. Human κ opiate receptor second extracellular loop elevates dynorphin's affinity for human μ/κ chimeras. J. Biol. Chem. 269:1994;25966-25969.
50. Wang W.W., Shahrestanifar M., Jin J., Howells R.D. Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. Natl. Acad. Sci. U. S. A. 92:1995;12436-12440.
51. Wess J. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol. Ther. 80:1998;231-264.
52. Xue J.-C., Chen C., Zhu J., Kunapuli S.P., de Riel J.K., Yu L., Liu-Chen L.-Y. The third extracellular loop of the μ opioid receptor is important for agonist selectivity. J. Biol. Chem. 270:1995;12977-12979.
53. Yamano Y., Ohyama K., Chaki S., Guo D.-F., Inagami T. Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. Biochem. Biophys. Res. Commun. 187:1992;1426-1431.
54. Yasuda K., Raynor K., Kong H., Breder C.D., Takeda J., Reisine T., Bell G.I. Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6736-6740.
55. Zadina J.E., Hackler L., Ge L.-J., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.